Smiths Medical voluntarily withdraws blood glucose monitors

Smiths Medical is pulling a line of blood glucose monitors from the market because supplies of compatible test strips have run out and no alternatives exist.

The St. Paul, Minn.-based company said March 30 that only its CoZmonitor systems are affected. It also said the FDA has been notified along with customers.  

Smiths Medical is a division of the Smiths Group, a multinational based in the U.K.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup